NRSNW   $0.14  16.67% Market Closed

NeuroSense Therapeutics Ltd
Total Cash 1.21M
totalCashPerShare 0.067
EBITDA -11.69M
Total Debt 36.00K
quickRatio 0.452
currentRatio 0.462
Total Revenue
debtToEquity
Revenue/Share
ROA -1.50788
ROE
grossProfits
freeCashflow -6.63M
operatingCashflow -10.20M
earningsGrowth
revenueGrowth
grossMargins 0.0
ebitdaMargins 0.0
operatingMargins 0.0
profitMargins 0.0
enterpriseValue
forwardPE
floatShares 13.46M
sharesOutstanding
sharesShort
sharesShortPriorMonth
dateShortInterest
sharesPercentSharesOut
heldPercentInsiders
heldPercentInstitutions
Short Ratio help_outline
shortPercentOfFloat
impliedSharesOutstanding
bookValue -0.094
Price To Book help_outline
earningsQuarterlyGrowth
netIncomeToCommon -9.80M
trailingEps -0.94%
forwardEps
enterpriseToEbitda
lastDividendValue
lastDividendDate
currentQuarterEstimate
institutionsCount 4
lastUpdated Oct. 17, 2024, 4 a.m.